TCL Archive DCCR Advisors Okay New Programs; $300,000 Year Demonstrations In Six Communities Supported November 17, 1978
TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013